Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
A. Multivariate cox regression analysis for parameters associated with all cause deaths | ||||
Diabetes | 1.603 [0.919–2.797] | 0.097 | 2.172 [1.225–3.925] | 0.010* |
Hypertension | 0.658 [0.407–1.064] | 0.088 | 1.519 [0.926–2.492] | 0.098 |
Dyslipidemia | 0.906 [0.531–1.544] | 0.716 | 1.232 [0.715–2.122] | 0.452 |
Smoke | 1.784 [1.119–2.844] | 0.045 | 1.133 [0.694–1.851] | 0.621 |
LVEF < 50% | 1.176 [0.727–1.901] | 0.51 | 0.901 [0.558–1.453] | 0.669 |
Bas.Lesion length | 0.953 [0.849–1.070] | 0.415 | 0.973 [0.866–1.092] | 0.638 |
Obesity | 0.964 [0.529–1.758] | 0.906 | 0.952 [0.493–1.841] | 0.885 |
Incretin | 0.901 [0.528–1.535] | 0.700 | 1.274 [0.664–2.447] | 0.466 |
VD-3 | 0.859 [0.493–1.497] | 0.592 | 1.284 [0.727–2.268] | 0.389 |
HsCRP | 1.188 [0.545–2.191] | 0.665 | 0.623 [0.011–3.247] | 0.858 |
M1/M2 ratio | 0.958 [0.438–2.088] | 0.913 | 1.136 [0.319–3.221] | 0.922 |
LowGLP-1 | 0.901 [0.413–1.965] | 0.793 | 3.714 [0.215–4.902] | 0.922 |
B. Multivariate cox regression analysis is for parameters associated with cardiac deaths | ||||
Diabetes | 1.663 [0.951–2.908] | 0.075 | 2.253 [1.245–4.078] | 0.007* |
Hypertension | 0.705 [0.433–1.146] | 0.159 | 1.438 [0.871–2.375] | 0.155 |
Dyslipidemia | 0.959 [0.561–1.642] | 0.88 | 1.174 [0.679–2.031] | 0.565 |
Smoke | 1.757 [1.092–2.828] | 0.02 | 1.024 [0.626–1.675] | 0.924 |
LVEF < 50% | 1.049 [0.653–1.386] | 0.842 | 0.877 [0.538–1.430] | 0.601 |
Bas.Lesion length | 0.942 [0.837–1.061] | 0.326 | 0.961 [0.853–1.081] | 0.638 |
Obesity | 1.017 [0.556–1.860] | 0.956 | 0.859 [0.441–1.673] | 0.656 |
Incretin | 0.816 [0.466–1.427] | 0.475 | 1.531 [0.762–3.074] | 0.231 |
VD-3 | 0.838 [0.473–1.484] | 0.544 | 1.285 [0.716–2.308] | 0.401 |
HsCRP | 1.244 [0.569–2.117] | 0.584 | 7.546 [0.716–8.403] | 0.859 |
M1/M2 ratio | 1.003 [0.459–2.191] | 0.994 | 1.107 [0.011–4.934] | 0.991 |
LowGLP-1 | 0.944 [0.432–2.62] | 0.885 | 4.029 [0.028–4.802] | 0.823 |
C. Multivariate cox regression analysis is for parameters associated with major adverse cardiac events (MACE) | ||||
Diabetes | 0.952 [0.621–1.461] | 0.822 | 1.962 [1.124–3.422] | 0.018* |
Hypertension | 0.929 [0.678–1.274] | 0.649 | 1.058 [0.751–1.490] | 0.748 |
Dyslipidemia | 0.899 [0.634–1.275] | 0.55 | 1.148 [0.775–1.698] | 0.748 |
Smoke | 1.158 [0.839–1.598] | 0.372 | 0.829 [0.578–1.190] | 0.309 |
LVEF < 50% | 0.994 [0.725–1.363] | 0.969 | 0.277 [0.590–1.163] | 0.829 |
Bas.Lesion length | 1.032 [0.955-1.115] | 0.048 | 1.023 [0.930–1.126] | 0.637 |
Obesity | 0.320 [0.235-0.437] | 0.001 | 1.528 [0.509-2.204] | 0.064 |
Incretin | 0.257 [0.187–0.355] | 0.001 | 0.565 [0.387–0.824] | 0.003* |
VD-3 | 1.806 [1.167–2.794] | 0.008 | 1.173 [0.728–1.888] | 0.513 |
HsCRP | 35.947 [26.067–49.553] | 0.001 | 1.938 [0.908–4.137] | 0.087 |
M1/M2 ratio | 0.019 [0.014–0.027] | 0.001 | 0.773 [0.293–2.037] | 0.603 |
LowGLP-1 | 0.018 [0.012–0.025] | 0.001 | 1.528 [1.059–2.204] | 0.024* |